Cuspis Capital III Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CAD 0.706206 million compared to CAD 0.042378 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 CAD | +2.33% | +2.33% | -37.55% |
05-27 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
04-30 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.55% | 17.2M | |
+51.54% | 795B | |
+41.11% | 627B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.74% | 245B | |
+1.23% | 222B | |
+11.82% | 215B | |
+3.64% | 160B |
- Stock Market
- Equities
- CYTO Stock
- News Cytophage Technologies Ltd.
- Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022